Drug profile · INN
rilpivirine
EDURANT
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
rilpivirine (EDURANT) is an FDA-listed pharmaceutical active ingredient. Associated with Janssen-Cilag Pty Ltd. Route of administration: oral. Current US regulatory status: approved.
Key facts
INN rilpivirine
Brand EDURANT
Route ORAL
Formulation TABLET
ATC code J05AG05
Originator Janssen-Cilag Pty Ltd
Frequently asked questions
What is rilpivirine?
rilpivirine (EDURANT) is an FDA-listed pharmaceutical active ingredient. Associated with Janssen-Cilag Pty Ltd. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for rilpivirine?
EDURANT is a marketed brand name for rilpivirine. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of rilpivirine?
rilpivirine has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.